{"id":"https://openalex.org/W7225403447","doi":"https://doi.org/10.33380/2305-2066-2026-15-4-2370","title":"Prediction of the mechanisms of hepatotropic action of maloben using molecular docking","display_name":"Prediction of the mechanisms of hepatotropic action of maloben using molecular docking","publication_year":2026,"publication_date":"2026-11-06","ids":{"openalex":"https://openalex.org/W7225403447","doi":"https://doi.org/10.33380/2305-2066-2026-15-4-2370"},"language":"en","primary_location":{"id":"doi:10.33380/2305-2066-2026-15-4-2370","doi":"https://doi.org/10.33380/2305-2066-2026-15-4-2370","is_oa":true,"landing_page_url":"https://doi.org/10.33380/2305-2066-2026-15-4-2370","pdf_url":"https://www.pharmjournal.ru/jour/article/download/2501/1562","source":{"id":"https://openalex.org/S4210178334","display_name":"Drug development & registration","issn_l":"2305-2066","issn":["2305-2066","2658-5049"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development & registration","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.pharmjournal.ru/jour/article/download/2501/1562","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089905041","display_name":"Artur V. Sauts","orcid":"https://orcid.org/0000-0002-2815-885X","observed_orcids":["https://orcid.org/0000-0002-2815-885X"]},"institutions":[{"id":"https://openalex.org/I4210166666","display_name":"Saint Petersburg University of Management and Economics","ror":"https://ror.org/05b4kax95","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210166666"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A. V. Sauts","raw_affiliation_strings":["Saint Petersburg State Chemical and Pharmaceutical University (SPCPU)","Saint Petersburg University of Management Technologies and Economics"],"raw_orcid":"https://orcid.org/0000-0002-2815-885X","affiliations":[{"raw_affiliation_string":"Saint Petersburg State Chemical and Pharmaceutical University (SPCPU)","institution_ids":[]},{"raw_affiliation_string":"Saint Petersburg University of Management Technologies and Economics","institution_ids":["https://openalex.org/I4210166666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039074010","display_name":"\u041f\u0440\u0438\u0445\u043e\u0434\u044c\u043a\u043e \u0412\u0435\u0440\u043e\u043d\u0438\u043a\u0430 \u0410\u043b\u0435\u043a\u0441\u0430\u043d\u0434\u0440\u043e\u0432\u043d\u0430","orcid":"https://orcid.org/0000-0002-4690-1811","observed_orcids":["https://orcid.org/0000-0002-4690-1811"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. A. Prikhodko","raw_affiliation_strings":["Saint Petersburg State Chemical and Pharmaceutical University (SPCPU)"],"raw_orcid":"https://orcid.org/0000-0002-4690-1811","affiliations":[{"raw_affiliation_string":"Saint Petersburg State Chemical and Pharmaceutical University (SPCPU)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002201376","display_name":"I. A. Titovich","orcid":"https://orcid.org/0000-0002-1343-4663","observed_orcids":["https://orcid.org/0000-0002-1343-4663"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. A. Titovich","raw_affiliation_strings":["Saint Petersburg State Chemical and Pharmaceutical University (SPCPU)"],"raw_orcid":"https://orcid.org/0000-0002-1343-4663","affiliations":[{"raw_affiliation_string":"Saint Petersburg State Chemical and Pharmaceutical University (SPCPU)","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021802900","display_name":"Sergey V. Okovityi","orcid":"https://orcid.org/0000-0003-4294-5531","observed_orcids":["https://orcid.org/0000-0003-4294-5531"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. V. Okovityi","raw_affiliation_strings":["Saint Petersburg State Chemical and Pharmaceutical University (SPCPU)"],"raw_orcid":"https://orcid.org/0000-0003-4294-5531","affiliations":[{"raw_affiliation_string":"Saint Petersburg State Chemical and Pharmaceutical University (SPCPU)","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.016699999570846558,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-alcoholic-fatty-liver-disease","display_name":"non-alcoholic fatty liver disease","score":0.8140000104904175},{"id":"https://openalex.org/keywords/hepatoprotective-mechanism","display_name":"hepatoprotective mechanism","score":0.7139999866485596},{"id":"https://openalex.org/keywords/ppargamma","display_name":"PPAR\u03b3","score":0.9039999842643738},{"id":"https://openalex.org/keywords/farnesoid-x-receptor","display_name":"farnesoid X receptor","score":0.9929999709129333},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.6579999923706055},{"id":"https://openalex.org/keywords/drug-likeness","display_name":"drug-likeness","score":0.5609999895095825},{"id":"https://openalex.org/keywords/binding-energy","display_name":"binding energy","score":0.4690000116825104},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.843999981880188},{"id":"https://openalex.org/keywords/bezafibrate","display_name":"bezafibrate","score":0.9900000095367432}],"concepts":[{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.7117999792098999},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6295999884605408},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6025000214576721},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.529699981212616},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.41609999537467957},{"id":"https://openalex.org/C203862802","wikidata":"https://www.wikidata.org/wiki/Q14905041","display_name":"Farnesoid X receptor","level":5,"score":0.40869998931884766},{"id":"https://openalex.org/C63932345","wikidata":"https://www.wikidata.org/wiki/Q422500","display_name":"Nuclear receptor","level":4,"score":0.40230000019073486},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39640000462532043},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.3644999861717224},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3580999970436096},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.34929999709129333},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.3488999903202057},{"id":"https://openalex.org/C178910836","wikidata":"https://www.wikidata.org/wiki/Q2196961","display_name":"Molecular model","level":2,"score":0.32839998602867126},{"id":"https://openalex.org/C59593255","wikidata":"https://www.wikidata.org/wiki/Q901663","display_name":"Molecular dynamics","level":2,"score":0.31769999861717224},{"id":"https://openalex.org/C51639874","wikidata":"https://www.wikidata.org/wiki/Q167149","display_name":"Plasma protein binding","level":2,"score":0.3174000084400177},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.314300000667572},{"id":"https://openalex.org/C127078168","wikidata":"https://www.wikidata.org/wiki/Q138639","display_name":"Peroxisome","level":3,"score":0.29829999804496765},{"id":"https://openalex.org/C25057246","wikidata":"https://www.wikidata.org/wiki/Q1344441","display_name":"Molecular mechanics","level":3,"score":0.29760000109672546},{"id":"https://openalex.org/C30095370","wikidata":"https://www.wikidata.org/wiki/Q899488","display_name":"Protonation","level":3,"score":0.2953000068664551},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.28439998626708984},{"id":"https://openalex.org/C47701112","wikidata":"https://www.wikidata.org/wiki/Q735188","display_name":"Protein structure","level":2,"score":0.2703000009059906},{"id":"https://openalex.org/C121587506","wikidata":"https://www.wikidata.org/wiki/Q6888113","display_name":"Mode of action","level":2,"score":0.2671000063419342},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.2653999924659729},{"id":"https://openalex.org/C23589133","wikidata":"https://www.wikidata.org/wiki/Q412005","display_name":"Hormone receptor","level":4,"score":0.26190000772476196},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.25690001249313354}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.33380/2305-2066-2026-15-4-2370","doi":"https://doi.org/10.33380/2305-2066-2026-15-4-2370","is_oa":true,"landing_page_url":"https://doi.org/10.33380/2305-2066-2026-15-4-2370","pdf_url":"https://www.pharmjournal.ru/jour/article/download/2501/1562","source":{"id":"https://openalex.org/S4210178334","display_name":"Drug development & registration","issn_l":"2305-2066","issn":["2305-2066","2658-5049"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development & registration","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.33380/2305-2066-2026-15-4-2370","doi":"https://doi.org/10.33380/2305-2066-2026-15-4-2370","is_oa":true,"landing_page_url":"https://doi.org/10.33380/2305-2066-2026-15-4-2370","pdf_url":"https://www.pharmjournal.ru/jour/article/download/2501/1562","source":{"id":"https://openalex.org/S4210178334","display_name":"Drug development & registration","issn_l":"2305-2066","issn":["2305-2066","2658-5049"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development & registration","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225403447.pdf","grobid_xml":"https://content.openalex.org/works/W7225403447.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1978701318","https://openalex.org/W2008059340","https://openalex.org/W2102377211","https://openalex.org/W2616258954","https://openalex.org/W2769250691","https://openalex.org/W2885086743","https://openalex.org/W2896914840","https://openalex.org/W2906059785","https://openalex.org/W3179196729","https://openalex.org/W3200266873","https://openalex.org/W3210393795","https://openalex.org/W4205859963","https://openalex.org/W4224663364","https://openalex.org/W4248107770","https://openalex.org/W4296331184","https://openalex.org/W4311904534","https://openalex.org/W4315619045","https://openalex.org/W4323670059","https://openalex.org/W4353055912","https://openalex.org/W4381681857","https://openalex.org/W4389341650","https://openalex.org/W4398769581","https://openalex.org/W4399435116","https://openalex.org/W4402146695","https://openalex.org/W4404578065","https://openalex.org/W4405564991","https://openalex.org/W4405795867","https://openalex.org/W4407743181","https://openalex.org/W4408581906","https://openalex.org/W4408924400","https://openalex.org/W4412198648","https://openalex.org/W4413116650","https://openalex.org/W4414376452","https://openalex.org/W4416797443","https://openalex.org/W7138956279","https://openalex.org/W7154602421"],"related_works":["https://openalex.org/W4405840394","https://openalex.org/W4403112829","https://openalex.org/W2138798968","https://openalex.org/W4366986093","https://openalex.org/W3208161049","https://openalex.org/W4214779576","https://openalex.org/W4200198957","https://openalex.org/W4310531097","https://openalex.org/W4316037225","https://openalex.org/W4308863515"],"abstract_inverted_index":{"Introduction.":[0],"Non-alcoholic":[1],"(metabolic":[2],"dysfunction-associated)":[3],"fatty":[4],"liver":[5],"disease":[6],"(NAFLD)":[7],"encompasses":[8],"a":[9,263,324],"spectrum":[10],"of":[11,22,59,69,78,80,90,120,177,193,259,266,280,304],"common":[12],"pathological":[13],"conditions":[14,34],"associated":[15],"with":[16,103,114,180,253,312],"systemic":[17],"metabolic":[18,302],"dysfunction.":[19],"The":[20,39,67,109,295],"development":[21],"new":[23],"effective":[24],"and":[25,31,64,86,144,150,156,170,184,198,212,240,269,274,282,291,301],"safe":[26],"pharmacological":[27],"therapies":[28],"for":[29,53,165,191,222,288],"NAFLD":[30],"its":[32,56,310],"comorbid":[33],"remains":[35],"an":[36,251],"ongoing":[37],"challenge.":[38],"malonic":[40],"acid":[41],"derivative":[42],"maloben":[43,81,91,178,305,321],"(sodium":[44],"4,4\u2019-(propanediamido)dibenzoate)":[45],"is":[46],"currently":[47],"undergoing":[48],"phase":[49],"II":[50],"clinical":[51],"trials":[52],"NAFLD;":[54],"however,":[55,246],"molecular":[57,83,264],"mechanism":[58],"action":[60,79],"requires":[61],"further":[62,223],"investigation":[63],"clarification.":[65],"Aim.":[66],"aim":[68],"this":[70],"study":[71],"was":[72,97],"to":[73,255],"investigate":[74],"the":[75,100,104,118,128,134,160,166,181,186,203,208,213,227,247,299],"potential":[76],"mechanisms":[77],"using":[82,99],"docking.":[84],"Materials":[85],"methods.":[87],"Molecular":[88,172],"docking":[89,173,228],"structures":[92,179],"protonated":[93],"at":[94],"physiological":[95],"pH":[96],"performed":[98],"Schr\u00f6dinger":[101],"Suite":[102],"Glide":[105],"XP":[106],"scoring":[107],"function.":[108],"target":[110],"molecules":[111],"included":[112],"proteins":[113],"established":[115],"roles":[116],"in":[117],"pathogenesis":[119],"NAFLD,":[121],"including":[122],"Kelch-like":[123],"ECH-associated":[124],"protein":[125],"1":[126,131],"(KEAP-1),":[127],"glucagon-like":[129],"peptide":[130],"receptor":[132,137,141],"(GLP-1R),":[133],"farnesoid":[135],"X":[136],"(FXR),":[138],"peroxisome":[139],"proliferator-activated":[140],"\u03b3":[142],"(PPAR-\u03b3),":[143],"thyroid":[145],"hormone":[146],"receptors":[147],"(THR)":[148],"\u03b2":[149],"\u03b1.":[151],"Docking":[152],"results":[153,296],"were":[154,217],"evaluated":[155],"interpreted":[157],"based":[158],"on":[159,226],"calculated":[161],"binding":[162,175,188,234],"energy":[163,189],"values":[164,190,279],"selected":[167,182],"targets.":[168],"Results":[169],"discussion.":[171],"generated":[174],"maps":[176],"targets":[183],"identified":[185],"lowest":[187],"two":[192],"them:":[194],"PPAR-\u03b3":[195,205,313],"(\u22128.425":[196],"kcal/mol)":[197],"FXR":[199,214],"(\u22128.369":[200],"kcal/mol).":[201],"Accordingly,":[202],"selective":[204],"agonist":[206,210,215],"pioglitazone,":[207],"PPAR-\u03b1/\u03b3/\u03b4":[209],"bezafibrate,":[211],"cilofexor":[216],"chosen":[218],"as":[219],"comparator":[220],"ligands":[221],"analysis.":[224],"Based":[225],"results,":[229],"these":[230],"compounds":[231],"exhibited":[232],"lower":[233],"energies":[235],"(\u221211.177":[236],"kcal/mol,":[237,239,242],"\u221210.907":[238],"\u221215.870":[241],"respectively)":[243],"than":[244],"maloben;":[245],"latter":[248],"may":[249,306,322],"have":[250],"advantage":[252],"respect":[254],"several":[256],"physicochemical":[257,317],"predictors":[258,318],"pharmacokinetics.":[260],"Maloben":[261],"has":[262],"weight":[265],"340.29":[267],"Da":[268],"octanol/water":[270],"partition":[271],"coefficient":[272],"(logD)":[273],"apparent":[275],"aqueous":[276],"solubility":[277],"(logS)":[278],"1.763":[281],"4.58,":[283],"respectively,":[284],"which":[285],"are":[286],"favorable":[287,325],"intestinal":[289],"absorption":[290],"membrane":[292],"permeability.":[293],"Conclusion.":[294],"indicate":[297],"that":[298,320],"hepatotropic":[300],"effects":[303],"be":[307],"mediated":[308],"by":[309],"interaction":[311],"and/or":[314],"FXR.":[315],"Several":[316],"suggest":[319],"exhibit":[323],"pharmacokinetic":[326],"profile":[327],"following":[328],"oral":[329],"administration.":[330]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-07T00:00:00"}